Chang, Jenny

Publications

Sort by

Co-Author Network

selected publications

Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer. Cell reports. 2020 Academic Article GET IT
Times cited: 14
Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods. Cancer. 2016 Academic Article GET IT
Times cited: 30
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion. Breast cancer research and treatment. 2016 Academic Article GET IT
Times cited: 27
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 Academic Article GET IT
Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. British journal of cancer. 2014 Academic Article GET IT
Times cited: 62
Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene. 2014 Academic Article GET IT
Times cited: 134
Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors. Cell research. 2014 Academic Article GET IT
Times cited: 23
Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 2014 Academic Article GET IT
Times cited: 43
Novel modeling of cancer cell signaling pathways enables systematic drug repositioning for distinct breast cancer metastases. Cancer research. 2013 Academic Article GET IT
Times cited: 42
Studying cancer stem cell dynamics on PDMS surfaces for microfluidics device design. Scientific reports. 2013 Academic Article GET IT
Times cited: 74
Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America. 2012 Academic Article GET IT
Times cited: 178
Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer prevention research (Philadelphia, Pa.). 2012 Academic Article GET IT
Times cited: 89
A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. Cancer research. 2011 Academic Article GET IT
Times cited: 82
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Oncogene. 2011 Academic Article GET IT
Times cited: 102
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Academic Article GET IT
Times cited: 51
The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 28
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase. Proceedings of the National Academy of Sciences of the United States of America. 2011 Academic Article GET IT
Times cited: 373
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients. Breast cancer research and treatment. 2010 Academic Article GET IT
Times cited: 53
Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 86
The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer. Breast cancer research and treatment. 2009 Academic Article GET IT
Times cited: 22
Treatment resistance in stem cells and breast cancer. Journal of mammary gland biology and neoplasia. 2009 Information Resource GET IT
Times cited: 63
Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer cell. 2007 Academic Article GET IT
Times cited: 292
Attribution of blame, self-forgiving attitude and psychological adjustment in women with breast cancer. Journal of behavioral medicine. 2007 Academic Article GET IT
Times cited: 49
Optimism, social support and psychosocial functioning among women with breast cancer. Psycho-oncology. 2006 Academic Article GET IT
Times cited: 136
Medical and psychosocial predictors of delay in seeking medical consultation for breast symptoms in women in a public sector setting. Journal of behavioral medicine. 2006 Academic Article GET IT
Times cited: 57
Self-forgiveness, spirituality, and psychological adjustment in women with breast cancer. Journal of behavioral medicine. 2005 Academic Article GET IT
Times cited: 75
Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer. Breast cancer research and treatment. 2003 Academic Article GET IT
Times cited: 53
Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 2003 Academic Article GET IT
Times cited: 220
Correlation between color power Doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 2002 Academic Article GET IT
Times cited: 96
Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary. Cancer. 2002 Information Resource GET IT
Times cited: 40
Benign and malignant breast masses and axillary nodes: evaluation with echo-enhanced color power Doppler US. Radiology. 2001 Academic Article GET IT
Times cited: 89
Clinical management of women with genomic BRCA1 and BRCA2 mutations. Breast cancer research and treatment. 2001 Information Resource GET IT
Times cited: 18
Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 27
Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer. 2000 Academic Article GET IT
Times cited: 158
Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology. 2000 Academic Article GET IT
Times cited: 126
Predictors of response to chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Article GET IT
Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2000 Academic Article GET IT
Times cited: 100
The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. British journal of cancer. 2000 Academic Article GET IT
Times cited: 43
Prognostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy. Breast cancer research and treatment. 2000 Academic Article GET IT
Times cited: 36
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Annals of oncology : official journal of the European Society for Medical Oncology. 1999 Academic Article GET IT
Times cited: 40
Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Mammography in Asian patients with BRCA1 mutations. Lancet (London, England). 1999 Article GET IT
Times cited: 19
Clinical studies of apoptosis and proliferation in breast cancer. Endocrine-related cancer. 1999 Information Resource GET IT
Times cited: 53
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 1998 Academic Article GET IT
Times cited: 266
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet (London, England). 1998 Academic Article GET IT
Times cited: 845
The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. British journal of cancer. 1998 Academic Article GET IT
Times cited: 28
Variation in endometrial thickening in women with amenorrhea on tamoxifen. Breast cancer research and treatment. 1998 Academic Article GET IT
Times cited: 30
A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast. European journal of cancer. 1997 Academic Article GET IT
Times cited: 49
Differential responses to chemoimmunotherapy in patients with metastatic malignant melanoma. European journal of cancer. 1997 Academic Article GET IT
Times cited: 2
A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas. British journal of cancer. 1997 Academic Article GET IT
Times cited: 12
Clubbing, arthralgia and haemoptysis in a patient with metastatic carcinoma of the breast. Annals of oncology : official journal of the European Society for Medical Oncology. 1996 Article GET IT
Times cited: 3
The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. Annals of oncology : official journal of the European Society for Medical Oncology. 1996 Academic Article GET IT
Times cited: 109
Foscarnet therapy for cytomegalovirus infection after allogeneic bone marrow transplantation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1996 Academic Article GET IT
Times cited: 5
Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients. Annals of oncology : official journal of the European Society for Medical Oncology. 1995 Academic Article GET IT
Times cited: 64
Platinum-Taxol non-cross resistance in epithelial ovarian cancer. British journal of cancer. 1995 Academic Article GET IT
Times cited: 23
A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome. Annals of oncology : official journal of the European Society for Medical Oncology. 1995 Academic Article GET IT
Times cited: 25
A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma. European journal of cancer. 1994 Academic Article GET IT
Times cited: 34

more ...

less ...

Background

education and training

M.B.,Ch.B., Cambridge University Medical School (United Kingdom) 1989
B.Sc., University of St. Andrews (United Kingdom) 1986

Contact

full name

Jenny Chang

VIVO Weill Cornell Medical College

Jenny Chang Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name